DS
GUTS icon

DRW Securities’s Fractyl Health GUTS Stock Holding History

DRW Securities’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,205
Closed -$18.2K – 1676
2025
Q2 		$18.2K Buy
+11,205
New +$18.1K ﹤0.01% 1065

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

DRW Securities's GUTS Position: Q3 2025 in Review

DRW Securities sold out of Fractyl Health (GUTS) in Q3 2025, closing a stake of 11,205 shares — an estimated $18.2K sold.

DRW Securities first reported a position in GUTS in Q2 2025 and held it in 1 quarter. The position peaked at $18.2K in Q2 2025. 74 funds tracked by Wall St. Rank hold GUTS as of Q3 2025.

  • DRW Securities reported no remaining Fractyl Health position as of Q3 2025 after selling out during the quarter.
  • DRW Securities sold 11,205 Fractyl Health shares in Q3 2025, an estimated $18.2K.
  • DRW Securities first reported a position in Fractyl Health in Q2 2025 and held it in 1 quarter.
  • DRW Securities's Fractyl Health position peaked at $18.2K in Q2 2025.
  • 74 funds tracked by Wall St. Rank held Fractyl Health as of Q3 2025.

Based on DRW Securities's 13F filing for Q3 2025, filed 14 Nov 2025.